https://pipelinereview.com/actinium-presents-first-ever-data-with-a-cd47-immunotherapy-in-combination-with-a-her2-directed-targeted-radiotherapy-in-solid-tumors-at-the-society-for-immunotherapy-for-cancer-sitc-conference/
Actinium Presents First Ever Data with a CD47 Immunotherapy in Combination with a HER2-Directed Targeted Radiotherapy in Solid Tumors at the Society for Immunotherapy for Cancer (SITC) Conference